De: R$ 140,15Por: R$ 112,12ou X de
Economia de R$ 28,03
Calcule o frete:
Para envios internacionais, simule o frete no carrinho de compras.
Calcule o valor do frete e prazo de entrega para a sua região
Editora
ISBN
Páginas
Idioma
Peso
AcabamentoSinopse
The New York Times Bestseller
A Financial Times Book of the Year 2025
A Guardian Book of the Year 2025
A detailed guide to a revolution transforming human longevity -- a breakthrough moment in the history of human health care -- from one of the most respected medical researchers in the world.
‘Fascinating . . . expertly surveys the latest approaches to managing the diseases and decline associated with ageing.’
Financial Times
'Extraordinary . . . a blueprint for the future.'
Siddhartha Mukherjee, author of The Emperor of All Maladies
'A tour de force.'
Venki Ramakrishnan, Nobel Laureate and author of Why We Die
In this breakthrough moment in the history of human health care, Super Agers is an evidenced-based guide to the revolution transforming human longevity. From his unique position as a leader overseeing millions in research funding, Dr Topol explains how you can benefit from new the treatments becoming available at a faster rate than ever, and the fundamental reasons — from semaglutides to AI — that we can be confident these breakthroughs will continue.
A Financial Times Book of the Year 2025
A Guardian Book of the Year 2025
A detailed guide to a revolution transforming human longevity -- a breakthrough moment in the history of human health care -- from one of the most respected medical researchers in the world.
‘Fascinating . . . expertly surveys the latest approaches to managing the diseases and decline associated with ageing.’
Financial Times
'Extraordinary . . . a blueprint for the future.'
Siddhartha Mukherjee, author of The Emperor of All Maladies
'A tour de force.'
Venki Ramakrishnan, Nobel Laureate and author of Why We Die
In this breakthrough moment in the history of human health care, Super Agers is an evidenced-based guide to the revolution transforming human longevity. From his unique position as a leader overseeing millions in research funding, Dr Topol explains how you can benefit from new the treatments becoming available at a faster rate than ever, and the fundamental reasons — from semaglutides to AI — that we can be confident these breakthroughs will continue.
Ficha Técnica
Especificações
| ISBN | 9781804960981 |
|---|---|
| Subtítulo | AN EVIDENCE-BASED APPROACH TO LONGEVITY |
| Pré venda | Sim |
| Peso | 312g |
| Autor para link | TOPOL ERIC |
| Livro disponível - pronta entrega | Não |
| Dimensões | 2.9 x 12.7 x 19.7 |
| Idioma | Inglês |
| Tipo item | Livro Importado |
| Número de páginas | 464 |
| Número da edição | 1ª EDIÇÃO - 2026 |
| Código Interno | 1209563 |
| Código de barras | 9781804960981 |
| Acabamento | PAPERBACK |
| Autor | TOPOL, ERIC |
| Editora | PENGUIN UK |
| Sob encomenda | Não |